CompletedNot Applicable

Treatment of Upper and Lower Respiratory Tract Infections in Young Children Using Probiotic

Malaysia120 participantsStarted 2019-08-29

Plain-language summary

This project aims to study the benefits of probiotics namely Bifidobacterium lactis M8 in treatment of upper and lower respiratory tract infections in young children, which are found common among children in Malaysia aged from 0-24 months.

Who can participate

Age range1 Month – 24 Months

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * young children aged 1-24 month, admitted to hospital for having respiratory diseases. * Willing to commit throughout the experiment Exclusion Criteria: * Long term medication due to certain severe illness * Glucose-6-phosphate dehydrogenase (G6PD) deficiency

What they're measuring

Duration of hospitalization in young children with respiratory tract infections upon administration of B. lactis M8

Timeframe: 4-weeks

Trial details

NCT IDNCT04122495

SponsorUniversiti Sains Malaysia

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-11-03

View on ClinicalTrials.gov More Respiratory Infection (for Example, Pneumonia, Bronchitis) trials